NCT05391126View on ClinicalTrials.gov

GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

NARecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Colorectal CancerPancreatic Cancer
Interventions
DRUG

Irinotecan

Usual dosing per package insert.

Trial Locations (1)

40506

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
lead

Reema A. Patel

OTHER

NCT05391126 - GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care | Biotech Hunter | Biotech Hunter